Cowen & Co Upgrades Pfizer (PFE) to Outperform
Tweet Send to a FriendGet Alerts PFE Hot Sheet
Price: $28.70 --0%
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Trade PFE Now!
Cowen & Co upgrades Pfizer (NYSE: PFE) from Neutral to Outperform.
To see all the upgrades/downgrades on shares of PFE, visit our Analyst Ratings page.
The 52-wk trading range is $14.00 - 20.36 and shares are currently at $17.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
To see all the upgrades/downgrades on shares of PFE, visit our Analyst Ratings page.
The 52-wk trading range is $14.00 - 20.36 and shares are currently at $17.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Pfizer (PFE) Discontinues Phase 3 Study of Inotuzumab Ozogamicin
- Baird Upgrades Vectren Corp. (VVC) to Outperform
- Drexel Hamilton Upgrades Northrop Grumman (NOC) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Cowen & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
